These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 31638206)
21. MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer. Liu F; Song D; Wu Y; Liu X; Zhu J; Tang Y Thorac Cancer; 2017 Nov; 8(6):613-619. PubMed ID: 28842954 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA‑92a promotes non‑small cell lung cancer cell growth by targeting tumor suppressor gene FBXW7. Ni D; Teng J; Cheng Y; Zhu Z; Zhuang B; Yang Z Mol Med Rep; 2020 Oct; 22(4):2817-2825. PubMed ID: 32945381 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-4465 suppresses tumor proliferation and metastasis in non-small cell lung cancer by directly targeting the oncogene EZH2. Sun J; Tian X; Lu SQ; Hu HB Biomed Pharmacother; 2017 Dec; 96():1358-1362. PubMed ID: 29169732 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB. Zhou GH; Lu YY; Xie JL; Gao ZK; Wu XB; Yao WS; Gu WG Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30446524 [TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761. Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873 [TBL] [Abstract][Full Text] [Related]
26. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer. Wang L; Kong W; Liu B; Zhang X Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172 [TBL] [Abstract][Full Text] [Related]
27. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4. Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells. Yang YR; Li YX; Gao XY; Zhao SS; Zang SZ; Zhang ZQ Int J Clin Exp Pathol; 2015; 8(9):10847-53. PubMed ID: 26617798 [TBL] [Abstract][Full Text] [Related]
29. The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis. Li S; Mei Z; Hu HB; Zhang X J Cell Physiol; 2018 Sep; 233(9):6679-6688. PubMed ID: 29215698 [TBL] [Abstract][Full Text] [Related]
30. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells. Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569 [TBL] [Abstract][Full Text] [Related]
31. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer. Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262 [TBL] [Abstract][Full Text] [Related]
32. A novel pathway in NSCLC cells: miR‑191, targeting NFIA, is induced by chronic hypoxia, and promotes cell proliferation and migration. Zhao J; Qiao CR; Ding Z; Sheng YL; Li XN; Yang Y; Zhu DY; Zhang CY; Liu DL; Wu K; Zhao S Mol Med Rep; 2017 Mar; 15(3):1319-1325. PubMed ID: 28075452 [TBL] [Abstract][Full Text] [Related]
33. Downregulation of miR‑138‑5p promotes non‑small cell lung cancer progression by regulating CDK8. Xing S; Xu Q; Fan X; Wu S; Tian F Mol Med Rep; 2019 Dec; 20(6):5272-5278. PubMed ID: 31638208 [TBL] [Abstract][Full Text] [Related]
34. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN. Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS Int J Clin Exp Pathol; 2015; 8(4):3827-34. PubMed ID: 26097565 [TBL] [Abstract][Full Text] [Related]
35. Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro. Lu J; Gu X; Liu F; Rui Z; Liu M; Zhao L Oncol Rep; 2019 May; 41(5):2987-2996. PubMed ID: 30896844 [TBL] [Abstract][Full Text] [Related]
36. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer. Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600 [TBL] [Abstract][Full Text] [Related]
37. Upregulated microRNA‑671‑3p promotes tumor progression by suppressing forkhead box P2 expression in non‑small‑cell lung cancer. Li ZY; Zhang ZZ; Bi H; Zhang QD; Zhang SJ; Zhou L; Zhu XQ; Zhou J Mol Med Rep; 2019 Oct; 20(4):3149-3159. PubMed ID: 31432170 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A. Liu M; Zhang Y; Zhang J; Cai H; Zhang C; Yang Z; Niu Y; Wang H; Wei X; Wang W; Gao P; Li H; Zhang J; Sun G Cell Death Dis; 2018 Feb; 9(2):189. PubMed ID: 29415994 [TBL] [Abstract][Full Text] [Related]
39. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Xiao P; Liu WL Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-590-5p suppresses the proliferation and invasion of non-small cell lung cancer by regulating GAB1. Xu BB; Gu ZF; Ma M; Wang JY; Wang HN Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5954-5963. PubMed ID: 30280777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]